Amneal Pharmaceuticals Inc.
AMRX | NASDAQ
$19.48
-$0.68 (-3.37%)
Sep 22, 2026, 11:56 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 54.78 | -20.84 | -12.65 | -2.31 | 68.43 | 7.37 |
PEG Ratio | -0.34 | 1 | 0.29 | 0 | -0.77 | -0.06 |
PS Ratio | 1.31 | 0.88 | 0.44 | 0.14 | 0.34 | 0.34 |
PB Ratio | -55.77 | -22.40 | 53.70 | 1.01 | 1.98 | 2.25 |
P/FCF Ratio | 14.63 | 11.12 | 3.84 | -11.78 | 3.68 | 2.15 |
P/OCF Ratio | 11.61 | 8.29 | 3.07 | 4.61 | 2.95 | 1.80 |
OCF/S Ratio | 11.26 | 10.56 | 14.44 | 2.94 | 11.55 | 19.02 |
Debt / Equity Ratio | -38.65 | -23.73 | 139.05 | 9.53 | 7.98 | 9.89 |
Quick Ratio | 1.48 | 0.86 | 0.94 | 1.17 | 1.52 | 1.57 |
Current Ratio | 2.17 | 1.41 | 1.63 | 1.88 | 2.24 | 2.29 |
Asset Turnover | 0.82 | 0.80 | 0.69 | 0.58 | 0.53 | 0.50 |
Interest Coverage | 1.75 | 0.96 | 0.97 | -0.60 | 1.12 | 0.62 |
Return on Equity | -101.78% | 106.97% | -424.61% | -43.56% | 2.95% | 30.03% |
Return on Assets | 1.96% | -3.34% | -2.42% | -3.42% | 0.27% | 2.27% |
Return on Invested Capital | 13.80% | 9.19% | 7.16% | -3.01% | 2.97% | -5.16% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 37.63% | 36.52% | 36.09% | 35.78% | 36.73% | 31.54% |
Net Profit Margin | 2.39% | -4.18% | -3.51% | -5.88% | 0.51% | 4.57% |
Pretax Profit Margin | 4.61% | -1.97% | -1.68% | -11.22% | 1.50% | -1.80% |
Operating Profit Margin | 14.02% | 8.92% | 8.54% | -4.29% | 7.29% | 4.57% |
FCF Margin | 8.94% | 7.88% | 11.55% | -1.15% | 9.27% | 15.92% |
EBITDA Margin | 20% | 15.74% | 20.92% | 19.90% | 19.16% | 17.35% |
Add to Watchlist
Select watchlists to add or remove AMRX